Responsiveness of lymphocytes to soluble extracts of prostatic tumors and abrogation by serum-blocking factor(s).
Preliminary evidence is presented suggestive of antitumor immunity, cross reactive with allogeneic extracts from tumors of the same type, and serum-blocking factor(s), which appear to be specific to autologous tumor only, in patients with prostatic cancer employing the method of leukocyte adherence inhibition.
D003429:Cross Reactions; D006801:Humans; D007111:Immunity, Cellular; D007957:Leukocyte Adherence Inhibition Test; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology*; D014020:Tissue Extracts / Q000276:immunology
D014020:Tissue Extracts